PL4341397T3 - Kompozycja i sposób umożliwiające edycję genomu - Google Patents
Kompozycja i sposób umożliwiające edycję genomuInfo
- Publication number
- PL4341397T3 PL4341397T3 PL22737844.5T PL22737844T PL4341397T3 PL 4341397 T3 PL4341397 T3 PL 4341397T3 PL 22737844 T PL22737844 T PL 22737844T PL 4341397 T3 PL4341397 T3 PL 4341397T3
- Authority
- PL
- Poland
- Prior art keywords
- composition
- genome editing
- enabling
- enabling genome
- editing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2106868A FR3124522B1 (fr) | 2021-06-25 | 2021-06-25 | Composition et méthode permettant l’édition génomique |
| PCT/EP2022/067351 WO2022269037A1 (fr) | 2021-06-25 | 2022-06-24 | Composition et méthode permettant l'édition génomique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4341397T3 true PL4341397T3 (pl) | 2026-03-30 |
Family
ID=79269675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22737844.5T PL4341397T3 (pl) | 2021-06-25 | 2022-06-24 | Kompozycja i sposób umożliwiające edycję genomu |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20250297242A1 (pl) |
| EP (1) | EP4341397B1 (pl) |
| JP (1) | JP2024522821A (pl) |
| KR (1) | KR20240025636A (pl) |
| CN (1) | CN117716029A (pl) |
| AU (1) | AU2022296859A1 (pl) |
| BR (1) | BR112023027276A2 (pl) |
| CA (1) | CA3221597A1 (pl) |
| DK (1) | DK4341397T3 (pl) |
| ES (1) | ES3060270T3 (pl) |
| FI (1) | FI4341397T3 (pl) |
| FR (1) | FR3124522B1 (pl) |
| PL (1) | PL4341397T3 (pl) |
| PT (1) | PT4341397T (pl) |
| WO (1) | WO2022269037A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116218971B (zh) * | 2023-01-10 | 2026-04-28 | 清华大学 | 一种高效染色质dna结合图谱测序方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US20140186843A1 (en) | 2012-12-12 | 2014-07-03 | Massachusetts Institute Of Technology | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| WO2019046636A1 (en) * | 2017-08-30 | 2019-03-07 | The Broad Institute, Inc. | CRISPR BASED EDITION OF HDR TYPE WITH DOUBLE SELECTION |
| EP4034640A4 (en) * | 2019-09-23 | 2023-10-25 | Regents Of The University Of Minnesota | GENETICALLY EDITED IMMUNE CELLS AND THERAPY METHODS |
-
2021
- 2021-06-25 FR FR2106868A patent/FR3124522B1/fr active Active
-
2022
- 2022-06-24 AU AU2022296859A patent/AU2022296859A1/en active Pending
- 2022-06-24 BR BR112023027276A patent/BR112023027276A2/pt unknown
- 2022-06-24 PL PL22737844.5T patent/PL4341397T3/pl unknown
- 2022-06-24 KR KR1020247002527A patent/KR20240025636A/ko active Pending
- 2022-06-24 WO PCT/EP2022/067351 patent/WO2022269037A1/fr not_active Ceased
- 2022-06-24 CA CA3221597A patent/CA3221597A1/fr active Pending
- 2022-06-24 FI FIEP22737844.5T patent/FI4341397T3/fi active
- 2022-06-24 PT PT227378445T patent/PT4341397T/pt unknown
- 2022-06-24 CN CN202280051685.5A patent/CN117716029A/zh active Pending
- 2022-06-24 US US18/573,692 patent/US20250297242A1/en active Pending
- 2022-06-24 DK DK22737844.5T patent/DK4341397T3/da active
- 2022-06-24 EP EP22737844.5A patent/EP4341397B1/fr active Active
- 2022-06-24 JP JP2023578194A patent/JP2024522821A/ja active Pending
- 2022-06-24 ES ES22737844T patent/ES3060270T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK4341397T3 (da) | 2026-02-16 |
| WO2022269037A1 (fr) | 2022-12-29 |
| KR20240025636A (ko) | 2024-02-27 |
| FI4341397T3 (fi) | 2026-02-03 |
| ES3060270T3 (en) | 2026-03-25 |
| PT4341397T (pt) | 2026-01-20 |
| CA3221597A1 (fr) | 2022-12-29 |
| EP4341397B1 (fr) | 2025-11-26 |
| CN117716029A (zh) | 2024-03-15 |
| FR3124522A1 (fr) | 2022-12-30 |
| EP4341397A1 (fr) | 2024-03-27 |
| US20250297242A1 (en) | 2025-09-25 |
| FR3124522B1 (fr) | 2025-02-28 |
| BR112023027276A2 (pt) | 2024-03-12 |
| AU2022296859A1 (en) | 2024-01-18 |
| JP2024522821A (ja) | 2024-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2637278B (en) | Compositions and methods for gene editing | |
| EP4267743A4 (en) | Compositions and methods for epigenetic editing | |
| EP4121522A4 (en) | METHODS AND COMPOSITIONS FOR DIRECTED GENOMIC EDITING | |
| EP4133072A4 (en) | CHEMICALLY MODIFIED GUIDE RNAS FOR GENOME EDITING WITH CAS9 | |
| EP4367227A4 (en) | Compositions and methods for efficient genome editing | |
| IL286335A (en) | Methods and compositions for editing nucleotide sequences | |
| IL288061A (en) | Compounds and methods for the treatment of covid-19 | |
| EP3691747A4 (en) | RNA COMPOSITIONS AND EDITING PROCEDURES | |
| EP4314257A4 (en) | METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES | |
| EP3796894A4 (en) | METHODS AND COMPOSITIONS FOR GENOMIC EDITING | |
| EP4304774A4 (en) | CEMENT COMPOSITIONS AND PROCESSES THEREOF | |
| PL4208046T3 (pl) | Kompozycje i sposoby | |
| EP4298212A4 (en) | Compositions and methods for targeting, editing, or modifying genes | |
| EP4486901A4 (en) | GENOME COMPOSITION AND EDITING METHODS | |
| EP4175651A4 (en) | METHODS AND COMPOSITIONS FOR MODIFYING THE B2M LOCUS IN B CELLS | |
| EP4463173A4 (en) | POSTBIOTIC COMPOSITIONS AND METHODS | |
| EP4423155C0 (en) | RADICAL HARDENING COMPOSITION | |
| EP4428233A4 (en) | NOVEL GENOME EDITING SYSTEM BASED ON C2C9 NUCLEASE AND ITS APPLICATION | |
| PL4341397T3 (pl) | Kompozycja i sposób umożliwiające edycję genomu | |
| EP4097225A4 (en) | Transposon systems for genome editing | |
| EP4085931A4 (en) | NEW PROCESS FOR TARGETED RNA EDITING | |
| EP3987024A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCED GENOMIC EDITING | |
| EP4199719A4 (en) | BIOCIDE COMPOSITION AND PROCESS | |
| JP1803834S (ja) | コンテンツ編集用コントローラ | |
| IL282608A (en) | Compositions and methods for nhej-mediated genome editing |